Products and Services

StemCore offers a range of services around pluripotent stem cell applications from provision of characterised embryonic lines and patient iPSC to collaborating with clients for the development of unique stem cell related tools.


Our staff bring extensive knowledge in stem cell biology and gene-editing to work with clients and understand their specific project requirements regarding complex genome modifications, disease models or cell specific designs. We have a proven track record in the production of iPSC from multiple adult cell types including fibroblasts and PBMCs from both normal and disease specific phenotypes. Our skills provide for a broad range of applications in pluripotent stem cell biology and cell-engineering outcomes. 

Drawing on our research team's experience, together with the guidance of our Scientific Advisory Committee we can offer a range of pluripotent cell related services including:

  • Provision of quality assured, well characterised, NIH approved human embryonic stem cells. Originally derived in Australia we provide cell lines MEL1, MEL2, MEL3 and MEL4.

  • Adult somatic cell reprogramming to induced pluripotent stem cells. Proven track record of successful reprogramming from a range of adult cell types both wild-type and with a disease phenotype.

  • CRISPR-CAS9 gene-editing for reporter lines, knock-in/out models, mutation correction and more.

  • Pluripotent cell characterisation. We can assess the pluripotent state and genomic integrity of your pluripotent cells using a wide variety of scientific methods.

  • We have well developed methods for differentiation into mesoderm, ectoderm and endoderm lineages. We can work with you to develop differentiation protocols to your cell type of interest in either monolayer or 3D aggregate based approaches.

  • We provide training in pluripotent cell tissue culture, differentiation methods and characterisation. 

  • If you don't see a specific option of interest here, we can always work with you one-on-one to help develop your pluripotent stem cell related research requirements.